Belhaven Biopharma

Developer of a life-saving medication designed for the treatment of anaphylaxis. The company is developing a portfolio of dry powder nasal medicines to provide convenient, safe, and rapid treatments i...

Healthcare
Raleigh, NC, United States
Founded 2020
3 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$51.2M
Last Round
N/A

Get the full picture

Create a free account to unlock Belhaven Biopharma's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required